Zalevsky Jonathan

CIK 00017898571 companySAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001789857

Recent Transactions

50 trades

Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2026-01-20$35.67/sh−3,867→ 21,354 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2025-11-25$54.28/sh−1,157→ 18,971 total
Award
NEKTAR THERAPEUTICS$NKTR
Stock Option
2025-11-21+4,766→ 4,766 total
Award
NEKTAR THERAPEUTICS$NKTR
Common Stock
2025-11-21+2,666→ 20,128 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2025-09-04$35.69/sh−307→ 17,462 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2025-09-04$32.43/sh−793→ 18,390 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2025-09-04$33.60/sh−432→ 17,958 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2025-09-04$34.41/sh−189→ 17,769 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2025-09-02$30.10/sh−485→ 19,183 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2025-08-19$26.59/sh−725→ 19,668 total
Award
NEKTAR THERAPEUTICS$NKTR
Stock Option
2025-08-19+16,666→ 16,666 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2025-05-19$0.67/sh−10,712→ 305,892 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2025-02-19$1.01/sh−10,300→ 316,604 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2024-12-19$0.94/sh−51,115→ 326,904 total
Award
NEKTAR THERAPEUTICS$NKTR
Common Stock
2024-12-13+135,000→ 378,019 total
Award
NEKTAR THERAPEUTICS$NKTR
Stock Option
2024-12-13+375,000→ 375,000 total
Award
NEKTAR THERAPEUTICS$NKTR
Stock Option
2024-12-13+270,000→ 270,000 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2024-11-19$1.01/sh−7,785→ 243,019 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2024-08-19$1.28/sh−6,866→ 250,804 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2024-05-17$1.75/sh−7,355→ 257,670 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2024-02-20$0.68/sh−9,014→ 265,025 total
Award
NEKTAR THERAPEUTICS$NKTR
Stock Option
2023-12-13+250,000→ 250,000 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2023-11-17$0.49/sh−9,646→ 274,039 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2023-08-16$0.78/sh−9,703→ 283,685 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2023-05-16$0.72/sh−9,791→ 293,388 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2023-02-16$3.00/sh−10,484→ 303,179 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2022-11-16$3.57/sh−13,460→ 313,663 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2022-08-18$4.65/sh−73,716→ 327,123 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2022-08-16$4.76/sh−10,560→ 400,839 total
Award
NEKTAR THERAPEUTICS$NKTR
Common Stock
2022-08-15+270,000→ 270,000 total
Award
NEKTAR THERAPEUTICS$NKTR
Common Stock
2022-08-15+135,000→ 411,399 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2022-05-16$3.95/sh−21,673→ 276,399 total
Award
NEKTAR THERAPEUTICS$NKTR
Common Stock
2022-05-15+23,950→ 298,072 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2022-02-16$10.95/sh−10,912→ 274,122 total
Award
NEKTAR THERAPEUTICS$NKTR
Common Stock
2021-12-16+52,950→ 285,034 total
Award
NEKTAR THERAPEUTICS$NKTR
Stock Option
2021-12-16+94,000→ 94,000 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2021-11-16$13.16/sh−20,869→ 232,084 total
Award
NEKTAR THERAPEUTICS$NKTR
Common Stock
2021-11-15+40,150→ 252,953 total
Award
NEKTAR THERAPEUTICS$NKTR
Stock Option
2021-10-12+71,550→ 71,550 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2021-08-16$13.83/sh−7,662→ 212,803 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2021-05-17$18.30/sh−31,111→ 235,065 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2021-02-16$22.37/sh−24,141→ 266,176 total
Award
NEKTAR THERAPEUTICS$NKTR
Common Stock
2020-12-18+40,000→ 290,317 total
Award
NEKTAR THERAPEUTICS$NKTR
Stock Option
2020-12-18+71,500→ 71,500 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2020-11-23$16.40/sh−16,380→ 250,317 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2020-11-16$16.93/sh−29,618→ 266,697 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2020-08-17$19.67/sh−26,200→ 296,315 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2020-05-18$22.51/sh−4,558→ 322,515 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2020-02-18$22.35/sh−4,774→ 327,073 total
Award
NEKTAR THERAPEUTICS$NKTR
Stock Option
2019-12-12+20,100→ 20,100 total

Companies

NEKTAR THERAPEUTICS
Chief R&D Officer
$NKTR

Recent Filings

Address

C/O NEKTAR THERAPEUTICS 455 MISSION BAY BLVD SOUTH

SAN FRANCISCO, CA, 94158

View on SEC.gov